Shift to a Customer-Focused Approach and Expansion into New Areas
First written in FY2016. 19 of 25 entries say "Advanced", first in FY2019. Latest entry: 2026-10-20.
1 other company's latest entry also says "Advanced".
- 2026-07-29Cited as achievedEarnings presentation
「Although lower chemical-product sales due to a temporary shortage of raw materials reduced revenue, net sales increased year on year due to the consolidation of the Tokuyama Life Science (TLS) Group and higher sales of semiconductor-related products, among other factors.」
Consolidation of the TLS Group and higher sales of semiconductor-related products emerged as company-wide drivers of revenue growth. The results showed that the expansion already under way in healthcare and electronics was contributing to performance. - FY2026AdvancedAnnual report
「In the Electronics field, OCI Tokuyama Semiconductor Materials Sdn. Bhd. was established in Malaysia to manufacture and sell polysilicon semi-finished products for semiconductors with the South Korean OCI Group. By working with the manufacturing and sales base under construction in Vietnam, we will develop a production and supply system for polysilicon for semiconductors.」
Specific initiatives progressed in the growth areas of Electronics, Healthcare and Environment, including the joint venture with OCI in Malaysia, the Vietnam base, the acquisition of the Healthcare business, solar panel recycling and hydrogen-related operations. - FY2026-H1AdvancedAnnual report
「As a result, revenue in this segment was ¥2,681 million, up 37.8% year on year, and operating profit was ¥256 million, compared with an operating loss of ¥220 million in the same period of the previous year.」
Revenue in the environmental business segment increased 37.8% year on year, and the segment moved from an operating loss of ¥220 million to operating profit of ¥256 million. The improvement in the environmental business's performance was demonstrated. - FY2026-H1AdvancedAnnual report
「Under Medium-Term Management Plan 2025, we positioned “electronics,” “healthcare,” and “the environment” as growth businesses and are transforming our business portfolio with the aim of raising the sales ratio of growth businesses to at least 60% in fiscal 2030. We believe the target business should serve as a core business in our “healthcare” field.」
The acquisition of JSR's in-vitro diagnostic products business and other operations gave concrete form to the company's expansion into Healthcare and its business portfolio transformation. The target for the sales contribution of growth businesses in fiscal 2030 was also presented. - FY2025-H1AdvancedAnnual report
「As TOKUYAMA VIETNAM CO.,LTD. was newly established during the current interim consolidated accounting period, the subsidiary has been included in the scope of consolidation.」
A Vietnamese entity was newly established in the Advanced Electronic Materials segment and made a consolidated subsidiary. A specific overseas base has been established as part of the expansion into new areas and overseas markets. - FY2024-Q3WorsenedAnnual report
「As a result, revenue in this segment was ¥5,438 million, down 47.5% year on year, and the operating loss was ¥355 million, compared with operating profit of ¥316 million in the same period of the previous year.」
Revenue in the environmental business segment declined 47.5% year on year, and the segment moved from operating profit of ¥316 million in the same period of the previous year to an operating loss of ¥355 million. The deterioration in current performance in the environmental business continued from the previous quarter. - FY2024-Q2WorsenedAnnual report
「As a result, revenue in this segment was ¥4,341 million, down 31.5% year on year, and the operating loss was ¥307 million, compared with operating profit of ¥298 million in the same period of the previous year.」
Revenue in the environmental business segment declined 31.5% year on year, and the segment moved from operating profit of ¥298 million to an operating loss of ¥307 million. Current performance in the environmental business, positioned as a future core pillar, has deteriorated. - FY2023AdvancedAnnual report
「In the Electronics field during the current consolidated fiscal year, full-scale operations began in Taiwan at 台塑徳山精密化學股份有限公司, a manufacturer and seller of high-purity isopropyl alcohol for the electronics industry, while construction progressed in South Korea on a plant for STAC Co., Ltd., a joint venture with SK Geo Centric Co., Ltd.」
The company demonstrated specific progress in shifting its business portfolio toward the growth fields of Electronics, Healthcare and Environment, including the start of full-scale operations in the Taiwanese IPA business, construction of the STAC plant in South Korea and the launch of mass-production equipment for aluminum nitride filler. - FY2023-Q3AdvancedAnnual report
「As a result, revenue in this segment was ¥10,365 million, up 47.0% year on year, and operating profit was ¥316 million, compared with an operating loss of ¥520 million in the same period of the previous year.」
Revenue in the environmental business segment increased 47.0% year on year, and the segment improved from an operating loss of ¥520 million to operating profit of ¥316 million. The initiative to make the environmental business a future core pillar showed further progress in performance following the previous quarter. - FY2023-Q2AdvancedAnnual report
「As a result, revenue in this segment was ¥6,336 million, up 41.5% year on year, and operating profit was ¥298 million, compared with an operating loss of ¥354 million in the same period of the previous year.」
Revenue in the environmental business segment increased 41.5% year on year, and the segment moved from an operating loss of ¥354 million to operating profit of ¥298 million. The initiative to make the environmental business a future core pillar produced tangible progress in performance. - FY2023-Q1RestatedAnnual report
「In this segment, we will consolidate environmental businesses that had been dispersed across the Group and pursue new business development, with the aim of making the environmental business one of our future core businesses.」
The company reiterated its positioning of the consolidated environmental business as a future core pillar and its aim of pursuing new business development. - FY2022-Q3RestatedAnnual report
「This segment was newly established from the current consolidated fiscal year to consolidate environmental businesses that had been dispersed across the Group and pursue new business development, with the aim of making the environmental business one of the Group's future core businesses.」
The company reiterated its positioning of the consolidated environmental business as a future core pillar and its aim of pursuing new development. - FY2022-Q1AdvancedAnnual report
「This segment was newly established to consolidate environmental businesses that had been dispersed across the Group and pursue new business development, with the aim of making the environmental business one of the Group's future core businesses.」
The company newly established an environmental business segment by consolidating its environmental-related businesses and formalized its policy of pursuing new development with the business as a future core pillar. - FY2021-Q3AdvancedAnnual report
「As we established 台塑德山精密化學股份有限公司 on 30 October 2020, the subsidiary has been included in the scope of consolidation from the current third-quarter consolidated accounting period.」
A new company was established in Taiwan and included as a consolidated subsidiary from the third-quarter consolidated accounting period. Expansion overseas and into new areas, including the existing Taiwanese R&D base, is progressing through the establishment of a legal entity. - FY2020-Q3AdvancedAnnual report
「The medical diagnostic systems business posted higher profit as orders for clinical laboratory equipment systems increased.」
The medical diagnostic systems business reported an increase in orders for clinical laboratory equipment systems and higher profit, demonstrating order results from its expansion into new areas. - FY2020-Q1AdvancedAnnual report
「The medical diagnostic systems business posted higher revenue after winning a major domestic contract for an automated specimen testing system.」
The medical diagnostic systems business won a major domestic contract, demonstrating specific order results in the expansion into new areas. - FY2019AdvancedAnnual report
「To strengthen the ICT-related fields, which are growth businesses, we decided to expand the manufacturing plants for photoresist developer and high-purity aluminum nitride powder. By further expanding our supply capacity, we will ensure more stable supply while promoting development across a broad range of applications. We also opened a research institute in Taiwan as a new overseas base for expanding and enhancing the competitiveness of our semiconductor-related products business.」
The company decided to expand manufacturing plants for 2 products in the ICT-related fields and opened a research institute in Taiwan in March 2019. Specific bases and facilities were established to expand supply capacity, develop applications and advance local joint development. - FY2016First statedAnnual report
「By shifting to thoroughly customer-centric business activities and an R&D structure grounded in customer needs, we will expand into new areas by leveraging our proprietary technologies.」
As part of the restructuring of its business strategy, the company is shifting to customer-centric activities and R&D based on customer needs.